211 related articles for article (PubMed ID: 25058392)
1. Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma.
Rucksaken R; Pairojkul C; Pinlaor P; Khuntikeo N; Roytrakul S; Selmi C; Pinlaor S
PLoS One; 2014; 9(7):e103259. PubMed ID: 25058392
[TBL] [Abstract][Full Text] [Related]
2. A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma.
Boonjaraspinyo S; Juasook A; Boonmars T; Aukkanimart R; Silsirivanit A; Loilome W; Sriraj P; Wu Z; Ratanasuwan P
Asian Pac J Cancer Prev; 2015; 16(14):5779-85. PubMed ID: 26320451
[TBL] [Abstract][Full Text] [Related]
3. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
4. Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.
Sanchez TW; Zhang G; Li J; Dai L; Mirshahidi S; Wall NR; Yates C; Wilson C; Montgomery S; Zhang JY; Casiano CA
Mol Cell Proteomics; 2016 Dec; 15(12):3564-3580. PubMed ID: 27742740
[TBL] [Abstract][Full Text] [Related]
5. Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma.
Rucksaken R; Charoensuk L; Pinlaor P; Pairojkul C; Khuntikeo N; Pinlaor S
Cancer Biomark; 2017; 18(1):27-34. PubMed ID: 27814272
[TBL] [Abstract][Full Text] [Related]
6. Treponema denticola enolase contributes to the production of antibodies against ENO1 but not to the progression of periodontitis.
Lee A; Kim YC; Baek K; Alam J; Choi YS; Rheu Y; Shin YJ; Kim S; Kim HD; Song YW; Choi Y
Virulence; 2018; 9(1):1263-1272. PubMed ID: 30001173
[TBL] [Abstract][Full Text] [Related]
7. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW
Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242
[TBL] [Abstract][Full Text] [Related]
8. A Predictive Role of Autoantibodies Against the Epitope aa168-183 of ENO1 in the Occurrence of Miscarriage Related to Thyroid Autoimmunity.
He X; Liu Y; Wang H; Sun W; Lu Y; Shan Z; Teng W; Li J
Front Immunol; 2022; 13():890502. PubMed ID: 35707546
[TBL] [Abstract][Full Text] [Related]
9. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma.
Jiang Y; Zheng X; Jiao D; Chen P; Xu Y; Wei H; Qian Y
EBioMedicine; 2019 Feb; 40():422-431. PubMed ID: 30638862
[TBL] [Abstract][Full Text] [Related]
10. Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma.
Tummanatsakun D; Proungvitaya T; Roytrakul S; Limpaiboon T; Wongkham S; Wongkham C; Silsirivanit A; Somintara O; Sangkhamanon S; Proungvitaya S
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31454981
[TBL] [Abstract][Full Text] [Related]
11. Identification of serologic biomarkers for predicting microvascular invasion in hepatocellular carcinoma.
Yu YQ; Wang L; Jin Y; Zhou JL; Geng YH; Jin X; Zhang XX; Yang JJ; Qian CM; Zhou DE; Liu DR; Peng SY; Luo Y; Zheng L; Li JT
Oncotarget; 2016 Mar; 7(13):16362-71. PubMed ID: 26918350
[TBL] [Abstract][Full Text] [Related]
12. Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma.
Yonglitthipagon P; Pairojkul C; Bhudhisawasdi V; Mulvenna J; Loukas A; Sripa B
Clin Biochem; 2012 Jul; 45(10-11):827-34. PubMed ID: 22552009
[TBL] [Abstract][Full Text] [Related]
13. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma.
Loosen SH; Roderburg C; Kauertz KL; Pombeiro I; Leyh C; Benz F; Vucur M; Longerich T; Koch A; Braunschweig T; Ulmer TF; Heidenhain C; Tacke F; Binnebösel M; Schmeding M; Trautwein C; Neumann UP; Luedde T
J Hepatol; 2017 Oct; 67(4):749-757. PubMed ID: 28668580
[TBL] [Abstract][Full Text] [Related]
15. A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by
Teeravirote K; Luang S; Waraasawapati S; Boonsiri P; Wongkham C; Wongkham S; Silsirivanit A
Molecules; 2021 May; 26(9):. PubMed ID: 34066878
[TBL] [Abstract][Full Text] [Related]
16. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group.
Loilome W; Yooyuen S; Namwat N; Sithithaworn P; Puapairoj A; Kano J; Noguchi M; Miwa M; Yongvanit P
Tumour Biol; 2012 Dec; 33(6):2289-98. PubMed ID: 22922884
[TBL] [Abstract][Full Text] [Related]
17. Anti-α-enolase is a prognostic marker in postoperative lung cancer patients.
Hsiao KC; Shih NY; Chu PY; Hung YM; Liao JY; Chou SW; Yang YY; Chang GC; Liu KJ
Oncotarget; 2015 Oct; 6(33):35073-86. PubMed ID: 26551021
[TBL] [Abstract][Full Text] [Related]
18. Plasma phosphoproteome and differential plasma phosphoproteins with opisthorchis viverrini-related cholangiocarcinoma.
Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K
Asian Pac J Cancer Prev; 2015; 16(3):1011-8. PubMed ID: 25735322
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma.
Mustafa MZ; Nguyen VH; Le Naour F; De Martin E; Beleoken E; Guettier C; Johanet C; Samuel D; Duclos-Vallee JC; Ballot E
J Transl Med; 2016 Jan; 14():17. PubMed ID: 26774260
[TBL] [Abstract][Full Text] [Related]
20. Exosomal piRNA profiling revealed unique circulating piRNA signatures of cholangiocarcinoma and gallbladder carcinoma.
Gu X; Wang C; Deng H; Qing C; Liu R; Liu S; Xue X
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):475-484. PubMed ID: 32369104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
